Episódios

  • Immune Thrombotic Thrombocytopenic Purpera (iTTP)
    May 19 2025

    Immune thrombotic thrombocytopenic purpura (iTTP) is a rare coagulopathic disorder characterized by immune-mediated thrombocytopenia and microangiopathic hemolytic anemia, that can cause life-threatening thrombosis. Coauthor Allyson M. Pishko, MD, MSCE, of the University of Pennsylvania joins JAMA Associate Editor David Simel, MD, MHS, to discuss the recent review of iTTP published in JAMA.

    Related Content:

    • Immune Thrombotic Thrombocytopenic Purpura
    Exibir mais Exibir menos
    22 minutos
  • Microbiome and Risk for Cancer Outcomes
    May 12 2025

    The human microbiome appears to influence risk for development and progression of cancer and response to treatment. Author Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, discusses basic science and clinical evidence regarding the human microbiome and cancer risk with JAMA Deputy Editor Mary McGrae McDermott, MD.

    Related Content:

    • The Microbiome and Cancer
    Exibir mais Exibir menos
    19 minutos
  • Diagnosis and Treatment of Endometriosis
    May 5 2025

    Endometriosis, a common cause of pelvic pain, affects approximately 10% of reproductive-age females. Author Sawsan As-Sanie, MD, MPH, University of Michigan, discusses the epidemiology, pathophysiology, diagnosis, and treatment of endometriosis with JAMA Senior Editor Karen E. Lasser, MD, MPH.

    Related Content:

    • Endometriosis
    Exibir mais Exibir menos
    16 minutos
  • Strategies for Talking With Parents About Vaccines
    Apr 30 2025

    What is the single most important thing to recognize when communicating with families about vaccines? Author Sean T. O’Leary, MD, MPH, of the University of Colorado Anschutz Medical Campus and Children’s Hospital Colorado joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss evidence-based approaches for discussions with parents about vaccines.

    Related Content:

    • Strategies for Communicating With Parents About Vaccines
    Exibir mais Exibir menos
    14 minutos
  • Non–Cystic Fibrosis (CF) Bronchiectasis in Adults
    Apr 28 2025

    Non-cystic fibrosis (CF) bronchiectasis, which affects approximately a half million people in the US, is a chronic lung condition that involves permanent bronchial dilation and inflammation; it is characterized by a productive cough and recurrent exacerbations. Author Alan F. Barker, MD, of Oregon Health and Science University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss non-CF bronchiectasis.

    Related Content:

    • Non–Cystic Fibrosis Bronchiectasis in Adults
    Exibir mais Exibir menos
    23 minutos
  • Vitamin D Guidelines for Healthy Children and Adults
    Apr 23 2025

    A JAMA Clinical Guidelines Synopsis summarizes the Endocrine Society’s most recent recommendations on vitamin D supplementation for disease prevention. Author Sherri-Ann M. Burnett-Bowie, MD, MPH, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS.

    Related Content:

    • Vitamin D for Prevention of Disease
    Exibir mais Exibir menos
    18 minutos
  • Discussing Surgery With Patients
    Apr 16 2025

    What are 3 fundamental communication skills needed when discussing surgery with patients? Author Lauren J. Taylor, MD, of the Central Virginia VA Health Care System discusses this and more with JAMA Senior Editor Anne Cappola, MD, ScM.

    Related Content:

    • Communicating With Patients About Surgery
    Exibir mais Exibir menos
    12 minutos
  • Treatment of Small Cell Lung Cancer
    Mar 31 2025

    Small cell lung cancer (SCLC) is a smoking-related malignancy that presents at an advanced stage in 70% of patients. Author Anne C. Chiang, MD, PhD, of the Yale University School of Medicine joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the epidemiology, treatment, and prognosis of SCLC.

    Related Content:

    • Small Cell Lung Cancer
    Exibir mais Exibir menos
    12 minutos